Your browser doesn't support javascript.
loading
Pesg PNH diagnosis, follow-up and treatment guidelines.
Sahin, Fahri; Akay, Olga Meltem; Ayer, Mesut; Dal, Mehmet Sinan; Ertop, Sehmus; Ilhan, Osman; Karakus, Volkan; Ozcan, Mehmet Ali; Ozkocaman, Vildan; Ozsan, Hayri; Salim, Ozan; Tobu, Mahmut; Tombak, Anil; Tuglular, Tulin Firatli; Yilmaz, Mehmet; Unal, Ali; Yenerel, Mustafa Nuri; Saydam, Guray.
Afiliação
  • Sahin F; Department of Hematology, Ege University Izmir, Turkey.
  • Akay OM; Department of Hematology, Koc University Istanbul, Turkey.
  • Ayer M; Department of Hematology, Haseki Training and Research Hospital Istanbul, Turkey.
  • Dal MS; Department of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Ankara, Turkey.
  • Ertop S; Department of Hematology, Bulent Ecevit University Zonguldak, Turkey.
  • Ilhan O; Department of Hematology, Ankara University Ankara, Turkey.
  • Karakus V; Department of Hematology, Mugla Sitki Kocman University Mugla, Turkey.
  • Ozcan MA; Department of Hematology, Dokuz Eylul University Izmir, Turkey.
  • Ozkocaman V; Department of Hematology, Uludag University Bursa, Turkey.
  • Ozsan H; Department of Hematology, Dokuz Eylul University Izmir, Turkey.
  • Salim O; Department of Hematology, Akdeniz University Antalya, Turkey.
  • Tobu M; Department of Hematology, Ege University Izmir, Turkey.
  • Tombak A; Department of Hematology, Mersin University Mersin, Turkey.
  • Tuglular TF; Department of Hematology, Marmara University Izmir, Turkey.
  • Yilmaz M; Department of Hematology, Gaziantep University Gaziantep, Turkey.
  • Unal A; Department of Hematology, Erciyes University Kayseri, Turkey.
  • Yenerel MN; Department of Hematology, Marmara University Izmir, Turkey.
  • Saydam G; Department of Hematology, Ege UniversityIzmir, Turkey; On behalf of PNH Education and Study Group (PESG).
Am J Blood Res ; 6(2): 19-27, 2016.
Article em En | MEDLINE | ID: mdl-27570707
ABSTRACT
PNH Education and Study Group (PESG) have been established in December 2013 as a non-profit, independent, medical organization www.pesg.org. Paroxysmal Nocturnal Hemoglobinuria (PNH) is a multi-systemic disease that should be treated with a multidisciplinary approach. Patients may apply to the clinics other than the hematology due to variability and diversity of clinical findings which lower the rate of diagnosis due to low awareness about PNH. PNH might be overlooked and diagnosis might be delayed. Regarding these, PESG was established with the collaboration of Immunology, Cardiology, Thorax Diseases (Pulmonology), Neurology, Gastroenterology, General Surgery and Urology specialists in addition to hematologists dealing with PNH. The PESG study group aims to increase the awareness about PNH, including training activities about PNH, strengthening the relations between clinics and planning of clinical studies as a goal. It is the first professional organization focusing on PNH, in Turkey.In this guideline, we want to facilitate the diagnosis attributes of physicians from all specializations that deal with PNH and its systemic complications. One can perceive this as a tailor made guideline of international guidelines but not a compilation.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article